Griffen

Griffin Discoveries is a biotechnology company focused on the discovery and development of small molecule drugs targeting G protein-coupled receptors (GPCRs). The company leverages its proprietary drug discovery platform to identify novel ligands for challenging targets, with a primary focus on histamine and chemokine receptors. Their research programs aim to address significant unmet needs in inflammatory disorders, allergic conditions, and oncology. By utilizing advanced molecular pharmacology and medicinal chemistry, Griffin Discoveries develops high-affinity compounds designed for improved therapeutic efficacy and safety profiles.